Robin Harper Cowie is CFO, Sec'y & Treasurer of BIODESIX INC. Currently has a direct ownership of 191,151 shares of BDSX, which is worth approximately $296,284. The most recent transaction as insider was on Aug 12, 2024, when has been sold 251 shares (Common Stock) at a price of $1.57 per share, resulting in proceeds of $394. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 191K
1.15% 3M change
45.32% 12M change
Total Value Held $296,284

Robin Harper Cowie Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2024
SELL
Open market or private sale
$394 $1.57 p/Share
251 Reduced 0.13%
191,151 Common Stock
Aug 09 2024
SELL
Open market or private sale
$1,158 $1.6 p/Share
724 Reduced 0.38%
191,402 Common Stock
Aug 08 2024
BUY
Exercise of conversion of derivative security
-
3,157 Added 1.62%
192,126 Common Stock
May 23 2024
BUY
Exercise of conversion of derivative security
-
13,080 Added 6.47%
188,969 Common Stock
May 21 2024
BUY
Exercise of conversion of derivative security
$1,767 $0.42 p/Share
4,209 Added 2.34%
175,889 Common Stock
May 09 2024
SELL
Open market or private sale
$1,450 $1.48 p/Share
980 Reduced 0.57%
171,680 Common Stock
May 08 2024
BUY
Exercise of conversion of derivative security
-
3,157 Added 1.8%
172,660 Common Stock
Feb 12 2024
SELL
Open market or private sale
$14,440 $1.66 p/Share
8,699 Reduced 4.88%
169,410 Common Stock
Feb 09 2024
SELL
Open market or private sale
$19,499 $1.92 p/Share
10,156 Reduced 5.39%
178,109 Common Stock
Feb 08 2024
BUY
Exercise of conversion of derivative security
-
51,692 Added 21.54%
188,265 Common Stock
Nov 10 2023
SELL
Open market or private sale
$603 $1.23 p/Share
491 Reduced 0.36%
136,573 Common Stock
Nov 09 2023
SELL
Open market or private sale
$623 $1.27 p/Share
491 Reduced 0.36%
137,064 Common Stock
Nov 08 2023
BUY
Exercise of conversion of derivative security
-
3,156 Added 2.24%
137,555 Common Stock
Aug 10 2023
SELL
Open market or private sale
$2,270 $1.27 p/Share
1,788 Reduced 1.34%
131,535 Common Stock
Aug 09 2023
SELL
Open market or private sale
$2,486 $1.39 p/Share
1,789 Reduced 1.32%
133,323 Common Stock
Aug 08 2023
BUY
Exercise of conversion of derivative security
-
11,575 Added 7.89%
135,112 Common Stock
Aug 03 2023
BUY
Grant, award, or other acquisition
$9,998 $1.62 p/Share
6,172 Added 4.76%
123,537 Common Stock
May 10 2023
SELL
Open market or private sale
$1,537 $1.58 p/Share
973 Reduced 0.82%
117,365 Common Stock
May 09 2023
SELL
Open market or private sale
$3,943 $1.57 p/Share
2,512 Reduced 2.08%
118,338 Common Stock
May 08 2023
BUY
Exercise of conversion of derivative security
-
11,575 Added 8.74%
120,850 Common Stock
Feb 09 2023
SELL
Open market or private sale
$7,596 $1.8 p/Share
4,220 Reduced 4.08%
99,275 Common Stock
Feb 08 2023
BUY
Exercise of conversion of derivative security
-
11,575 Added 10.06%
103,495 Common Stock
Nov 21 2022
BUY
Grant, award, or other acquisition
$19,999 $1.15 p/Share
17,391 Added 15.91%
91,920 Common Stock
Nov 10 2022
SELL
Open market or private sale
$1,614 $1.02 p/Share
1,583 Reduced 2.08%
74,529 Common Stock
Nov 09 2022
SELL
Open market or private sale
$2,078 $1.04 p/Share
1,999 Reduced 2.56%
76,112 Common Stock
RHC

Robin Harper Cowie

CFO, Sec'y & Treasurer
Boulder, CO

Track Institutional and Insider Activities on BDSX

Follow BIODESIX INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BDSX shares.

Notify only if

Insider Trading

Get notified when an Biodesix Inc insider buys or sells BDSX shares.

Notify only if

News

Receive news related to BIODESIX INC

Track Activities on BDSX